Lupin's Q4 net profit at Rs 236 crore, sales rise 12.1% YoY

An improved product mix also helped Lupin expand its EBIDTA margin for the quarter by 690 basis points on year.

Related Keywords

India ,Nilesh Gupta , ,Earnings Before Interest ,Managing Director ,Results ,Lupin ,4 Results ,Q4 Numbers ,4 Earnings ,Lupin Q4 ,Drugmaker ,Pharmaceutical Company ,Dharma ,